Tuesday, September 26, 2017 6:32:23 AM
Sep 26, 2017
OTC Disclosure & News Service
-
EFSI Uses Solution to Protect Highly Sensitive Email Data
AUSTIN, TX / ACCESSWIRE / September 26, 2017 / CipherLoc Corporation (OTCQB: CLOK), a leading provider of highly secure data protection technology, today announced the successful installation of its recently announced secure email product with lead customer, Essential Fund Services International (''EFSI''). Designed for use with Microsoft Outlook clients, this new solution enables CipherLoc's patented data protection technology to be seamlessly integrated into the native Outlook email environment. The completion of this installation enables EFSI to place an ironclad layer of protection on all information being transacted daily via email. Due to the highly sensitive nature of the information EFSI handles, the protection of its data is of paramount importance.
EFSI (www.essentialfundadmin.com) is an independently owned, SOC I regulated, full service fund administration firm providing clients with a comprehensive suite of fund administration services. Based in New York City, it provides accounting, reporting and administrative services to the private investment community, including hedge funds, funds of funds, private equity funds, family offices, and separately managed accounts. EFSI, along with its affiliated partner Essential Fund Services, LLC (''EFS''), administers approximately $4 billion of client assets across over 90 reporting entities.
''We are pleased to have completed the initial installation of our innovative email protection product at a firm like EFSI where the protection of data is of critical importance,'' said Michael DeLaGarza, President and CEO of CipherLoc. ''We look forward to continue working with the EFSI team as we move to deploy other parts of the comprehensive CipherLoc solution onto a variety of its other desktop, server, mobile, and database platforms.''
Eric Jacobs, managing member of EFSI, commented, ''With the installation of CipherLoc's polymorphic and non-AES based encryption technology, we differentiate ourselves from other financial institutions. We are now using a cutting-edge technology that demonstrates a fiduciary respect above all others in our industry. Financial Services companies have an obligation to not simply comply with the failed industry standard, but to go above and beyond, especially since they are entrusted with confidential client data and its transmission.''
Deployment of the CipherLoc portfolio of products will continue throughout the third quarter of 2017 and will conclude in the fourth quarter of this year.
About CipherLoc Corporation (OTCQB: CLOK)
CipherLoc Corporation is a data security solutions company whose vision is simple - Protect the World's Data. Our highly innovative solutions are based on our patented Polymorphic Cipher Engine which is designed to take existing encryption algorithms and makes them better, faster, stronger, and massively scalable. We deliver easy-to-deploy software solutions that can be added to any existing product, service, or application. In short, we keep information safe in today's highly dangerous world.
For further information, please go to www.cipherloc.net.
Media Contact:
Mike Salas
msalas@cipherloc.net
SOURCE: CipherLoc Corporation
Copyright © 2017 Accesswire. All Rights Reserved
Recent SDCH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:54:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:48:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 12:05:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 12:00:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:57:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:55:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:53:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:51:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 12:15:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/05/2024 01:00:19 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/28/2023 10:25:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/27/2023 10:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:00:16 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/21/2023 02:09:12 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/11/2023 10:01:10 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/04/2023 03:58:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 10:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:13:59 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 11/03/2023 02:09:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:54:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:52:33 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM